Analyst Recommendations

Wedbush analyst issues BUY recommendation for UTHR on February 22, 2024 09:00AM ET. The previous analyst recommendation was Buy.UTHR was trading at $219.18 at issue of the analyst...

February 22, 2024   UTHR -5.63%

Leerink Partners analyst issues UNDERPERFORM recommendation for UTHR on February 22, 2024 09:00AM ET. The previous analyst recommendation was Underperform.UTHR was trading at $219.18 at issue of the...

February 22, 2024   UTHR -5.63%

Barclays analyst issues OVERWEIGHT recommendation for NEE on February 22, 2024 08:42AM ET. The previous analyst recommendation was Overweight.NEE was trading at $57.1 at issue of the analyst...

February 22, 2024   NEE -3.32%

Seaport Global analyst issues SELL recommendation for NEE on February 22, 2024 08:42AM ET. NEE was trading at $57.1 at issue of the analyst recommendation.The overall analyst consensus...

February 22, 2024   NEE -3.32%

Barclays analyst issues OVERWEIGHT recommendation for SRE on February 22, 2024 08:42AM ET. The previous analyst recommendation was Overweight.SRE was trading at $71.96 at issue of the analyst...

February 22, 2024   SRE 0.77%

Oppenheimer analyst issues OUTPERFORM recommendation for MRNA on February 22, 2024 02:32AM ET. The previous analyst recommendation was Neutral.MRNA was trading at $87.59 at issue of the analyst...

February 22, 2024   MRNA 0.51%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for MRNA on February 22, 2024 02:32AM ET. The previous analyst recommendation was Equal-Weight.MRNA was trading at $87.59 at issue of the...

February 22, 2024   MRNA 0.51%

Scotiabank analyst issues SECTOR OUTPERFORM recommendation for MOS on February 22, 2024 04:02AM ET. MOS was trading at $30.23 at issue of the analyst recommendation.The overall analyst consensus...

February 22, 2024   MOS 0.69%

HSBC analyst issues HOLD recommendation for MLM on February 22, 2024 02:48AM ET. MLM was trading at $536.3 at issue of the analyst recommendation.The overall analyst consensus :...

February 22, 2024   MLM 0.90%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for MRNA on February 22, 2024 02:32AM ET. The previous analyst recommendation was Equal-Weight.MRNA was trading at $87.59 at issue of the...

February 22, 2024   MRNA 0.51%